retatrutide mechanism triple agonist gip glp-1 glucagon Treatment with retatrutide, an agonist to GLP-1 glp 1 gip triple agonist

The opportunity for an oral GLP-1 medication with highly effective weight loss that is simpler to take may provide increased access and opportunities for better health for our patients with obesity and diabetes, said Deborah Horn, DO, MPH, professor and director of obesity medicine at McGovern Medical School at UTHealth Houston and principal author of the study

The present recommendations of the American and European Diabetes Associations are currently updating their actual recommendation for the treatment algorithm for T2D ( Tirzepatide may also become an important pharmacological tool for the treatment of obesity if data from the SURMOUNT-1 trial are confirmed in other clinical studies (82)

This blog explores how GLP-1 receptor agonists are redefining modern medicinebeyond glucose controlby improving metabolic health , protecting the heart , and reducing the bodys inflammatory burden

The remarkable, yet not extraordinary, human brain as a scaled-up primate brain and its associated cost

Louis College of Pharmacy Clinical Pharmacy Specialist, Primary Care Veterans Affairs St

Ozempic is first GLP-1 drug FDA-approved for kidney disease Novo Nordisk's GLP-1 agonist Ozempic has become the first drug in the class to be approved by the FDA to reduce the risk of worsening kidney disease in people with type 2 diabetes